1945Archives of Internal MedicineRequires access

INTRAVENOUS INJECTION OF ACACIA

John B. Johnson

Open publisher page 2 citations

Abstract

The management of edema in patients with chronic glomerulonephritis complicated by the syndrome of hypoproteinemia and massive proteinuria continues to be unsatisfactory. The immediate cause of the edema is the reduced osmotic pressure resulting from the hypoproteinemia. No clinical methods are available at present by which one can stop the proteinuria or stimulate production of plasma protein so that the plasma protein concentration will rise sufficiently to eliminate the edema. Administration of acacia in the treatment of nephrotic edema was first reported by Hartmann in 1933. 1 Since that time, many clinical reports have appeared, and much experimental work has been done on this subject. For the most part these reports have been unfavorable, with the result that acacia is not used extensively in the treatment of nephrotic edema. The opposition to the use of acacia is based on the following observations: Cases have been reported in which there

About this research paper

What this paper is about

The management of edema in patients with chronic glomerulonephritis complicated by the syndrome of hypoproteinemia and massive proteinuria continues to be unsatisfactory. The immediate cause of the edema is the reduced osmotic pressure resulting from the hypoproteinemia. No clinical methods are available at present by which one can stop the proteinuria or stimulate production of plasma protein so that the plasma protein concentration will rise sufficiently to eliminate the edema. Administration of acacia in the treatment of nephrotic edema was first reported by Hartmann in 1933. 1 Since that time, many clinical reports have appeared, and much experimental work has been done on this subject. For the most part these reports have been unfavorable, with the result that acacia is not used extensively in the treatment of nephrotic edema. The opposition to the use of acacia is based on the following observations: Cases have been reported in which there

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The management of edema in patients with chronic glomerulonephritis complicated by the syndrome of hypoproteinemia and massive proteinuria continues to be unsatisfactory. The immediate cause of the edema is the reduced osmotic pressure resulting from the hypoproteinemia. No clinical methods are available at present by which one can stop the proteinuria or stimulate production of plasma protein so that the plasma protein concentration will rise sufficiently to eliminate the edema. Administration of acacia in the treatment of nephrotic edema was first reported by Hartmann in 1933. 1 Since that time, many clinical reports have appeared, and much experimental work has been done on this subject. For the most part these reports have been unfavorable, with the result that acacia is not used extensively in the treatment of nephrotic edema. The opposition to the use of acacia is based on the following observations: Cases have been reported in which there

Key concepts: Acacia, Medicine, Biology, Botany

Related papers

Back to paper searchBrowse research topicsOriginal source
INTRAVENOUS INJECTION OF ACACIA — Research Paper | ScholarLens